» Articles » PMID: 35447722

Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema

Overview
Date 2022 Apr 21
PMID 35447722
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphedema is characterized by progressive and chronic tissue swelling and inflammation from local accumulation of interstitial fluid due to lymphatic injury or dysfunction. It is a debilitating condition that significantly impacts a patient's quality of life, and has limited treatment options. With better understanding of the molecular mechanisms and pathophysiology of lymphedema and advances in tissue engineering technologies, lymphatic tissue bioengineering and regeneration have emerged as a potential therapeutic option for postsurgical lymphedema. Various strategies involving stem cells, lymphangiogenic factors, bioengineered matrices and mechanical stimuli allow more precisely controlled regeneration of lymphatic tissue at the site of lymphedema without subjecting patients to complications or iatrogenic injuries associated with surgeries. This review provides an overview of current innovative approaches of lymphatic tissue bioengineering that represent a promising treatment option for postsurgical lymphedema.

Citing Articles

Biomaterials in the clinical treatment of lymphedema-a systematic review.

Drobot D, Shemy O, Zeltzer A J Vasc Surg Venous Lymphat Disord. 2023; 12(1):101676.

PMID: 37696416 PMC: 11523317. DOI: 10.1016/j.jvsv.2023.08.015.


Assessment of the Efficiency of Measuring Foot and Ankle Edema with a 3D Portable Scanner.

Beldame J, Sacco R, Munoz M, Masse M, Lalevee M Bioengineering (Basel). 2023; 10(5).

PMID: 37237619 PMC: 10215399. DOI: 10.3390/bioengineering10050549.


Recellularized lymph node scaffolds with human adipose-derived stem cells enhance lymph node regeneration to improve lymphedema.

Kang H, Moon S, Kim B, Myung Y, Lee J, Jeong J Sci Rep. 2023; 13(1):5397.

PMID: 37012287 PMC: 10070624. DOI: 10.1038/s41598-023-32473-z.

References
1.
Cho H, Sung W, Lee Y, Kwak S, Kim K . Two methods of extracorporeal shock-wave therapy in a rat model of secondary lymphedema: a pilot study. J Int Med Res. 2021; 49(6):3000605211024473. PMC: 8258771. DOI: 10.1177/03000605211024473. View

2.
Guc E, Briquez P, Foretay D, Fankhauser M, Hubbell J, Kilarski W . Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials. 2017; 131:160-175. DOI: 10.1016/j.biomaterials.2017.03.033. View

3.
Lin H, Wang W, Huang Y, Liao W, Lin T, Lin S . Decellularized Lymph Node Scaffolding as a Carrier for Dendritic Cells to Induce Anti-Tumor Immunity. Pharmaceutics. 2019; 11(11). PMC: 6920996. DOI: 10.3390/pharmaceutics11110553. View

4.
Alderfer L, Wei A, Hanjaya-Putra D . Lymphatic Tissue Engineering and Regeneration. J Biol Eng. 2018; 12:32. PMC: 6296077. DOI: 10.1186/s13036-018-0122-7. View

5.
Kwon S, Kwon Y, Lee T, Park G, Kim J . Recent advances in stem cell therapeutics and tissue engineering strategies. Biomater Res. 2019; 22:36. PMC: 6299977. DOI: 10.1186/s40824-018-0148-4. View